CelLBxHealth plc (AIM:CLBX)
1.050
0.00 (0.00%)
At close: Feb 13, 2026
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 11.93 million as of February 13, 2026. Its market cap has decreased by -77.16% in one year.
Market Cap
11.93M
Enterprise Value
10.33M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.05
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 11.93M, a decrease of -41.42%. That is a compound annual growth rate of -2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 11.93M | -4.55% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 85.92B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| Inspiration Healthcare Group | 17.31M |
| Cambridge Cognition Holdings | 16.54M |
| Oxford BioDynamics | 13.30M |
| genedrive | 11.07M |